Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 130 citing Natali: Vascular effects of improving metabolic control with metformin or rosiglitazone in.... (0.08 sec) 

Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and …

- diabetesjournals.org
F Pistrosch, K Herbrig, B Kindel, J Passauer, … - Diabetes, 2005 - Am Diabetes Assoc
Microalbuminuria, an early feature of diabetic nephropathy, indicates intrarenal
endothelial damage. In type 2 diabetes, microalbuminuria is strongly related to
insulin resistance. We therefore investigated whether rosiglitazone, an ...
Cited by 112 - Related articles - All 6 versions

Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases


E Cersosimo, RA DeFronzo - Diabetes/Metabolism Reviews - interscience.wiley.com
Cardiovascular disease affects approximately 60% of the adult population over
the age of 65 and represents the number one cause of death in the United States.
Coronary atherosclerosis is responsible for the vast majority of the ...
Cited by 88 - Related articles - BL Direct - All 3 versions

Comparison of rosiglitazone and metformin for treating HIV lipodystrophy: a randomized trial

- annals.org [PDF] 
JPH van Wijk, EJP de Koning, MC Cabezas… - Annals of internal medicine, 2005 - Am Coll Physicians
Comparison of Rosiglitazone and Metformin for Treating ... Jeroen PH van Wijk,
MD; Eelco JP de Koning, MD, PhD; Manuel Castro Cabezas, MD, PhD; Jos op't Roodt,
BSc; Jorge Joven, MD, PhD; Ton J. Rabelink, MD, PhD; and Andy I. Hoepelman, ...
Cited by 75 - Related articles - BL Direct - All 4 versions

Protection of the kidney by thiazolidinediones: an assessment from bench to bedside


PA Sarafidis, GL Bakris - Kidney international, 2006 - nature.com
The global epidemic of diabetes mellitus has led to a continuous increase in the
prevalence of diabetic nephropathy over the past years. Thus, diabetic
nephropathy is currently the number one cause of end-stage renal disease in ...
Cited by 72 - Related articles - BL Direct - All 4 versions

Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in …


A Natali, E Toschi, S Baldeweg, D Ciociaro, S … - Diabetes, 2006 - Am Diabetes Assoc
Vascular dysfunction, low-grade inflammation, insulin resistance, and impaired
fibrinolysis have each been reported to be present in type 2 diabetes, but their
relationships, and the role of obesity, have not been investigated. We ...
Cited by 57 - Related articles - BL Direct - All 5 versions

The role of insulin and the adipocytokines in regulation of vascular endothelial function


SA Ritchie, MA Ewart, CG Perry, JMC Connell, … - Clinical Science, 2004 - clinsci.org
Abbreviations: ADMA, asymmetric dimethylarginine; AMPK, AMP-activated protein
kinase; BMI, body mass index; CRP, C-reactive protein; ET-1, endothelin-1; FasL,
Fas ligand; HUVEC, human umbilical vein endothelial cell; ICAM-1, ...
Cited by 59 - Related articles - Cached - BL Direct - All 10 versions

Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and …


A Natali, E Ferrannini - Diabetologia, 2006 - Springer
Abstract Aims/hypothesis: Insulin resistance, which manifests itself as
endogenous glucose overproduction and reduced insulin-mediated glucose uptake,
is a core defect in type 2 diabetes. Metformin and the peroxisome ...
Cited by 56 - Related articles - BL Direct - All 3 versions

Effects of pioglitazone versus glipizide on body fat distribution, body water content, and …


A Basu, MD Jensen, F McCann, D … - Diabetes Care, 2006 - Am Diabetes Assoc
RESULTS—Pioglitazone increased (P < 0.001 from baseline) total body water
(+2.4 ± 0.5 l) accounting for 75% of the total weight gain (+3.1 ± 2.0 kg) but
did not alter vascular endothelial growth factor concentrations. Total ...
Cited by 55 - Related articles - BL Direct - All 6 versions

Treating insulin resistance in type 2 diabetes with metformin and thiazolidinediones


CJ Bailey - Diabetes Obesity and Metabolism, 2005 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 50 - Related articles - BL Direct - All 5 versions

PPAR dual agonists: are they opening Pandora's Box?


P Balakumar, M Rose, SS Ganti, P Krishan, M … - Pharmacological Research, 2007 - Elsevier
Cardiovascular disorders are the major cause of mortality in patients of
diabetes mellitus. Peroxisome proliferator activated receptors (PPARs) are
ligand-activated transcription factors of nuclear hormone receptor ...
Cited by 49 - Related articles - All 3 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google